Effect of the iChoose Kidney decision aid in improving knowledge about treatment options among transplant candidates: A randomized controlled trial
Rachel E. Patzer(Regenstrief Institute), Stephen O. Pastan(Emory University), Michael S. Wolf(Georgia Institute of Technology), John J. Friedewald(Northwestern University), Jennifer C. Gander(Kaiser Permanente), Thomas C. Pearson(Emory Healthcare), Sumit Mohan(Columbia University Irving Medical Center), Laura McPherson(Kaiser Permanente), Christian P. Larsen(Emory University Hospital), Allison L. Russell(Northwestern University), Daniela P. Ladner(Northwestern University), Mohua Basu(Emory University), Mariana C. Chiles(Columbia University Irving Medical Center)
Cited by 80
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
|Nature Reviews Nephrology|2020|703